Lucette A Cysique1,2,3, Emilia Łojek4, Theodore Ching-Kong Cheung5, Breda Cullen6, Anna Rita Egbert7, Jonathan Evans6, Maite Garolera8, Natalia Gawron9, Hetta Gouse10, Karolina Hansen4, Paweł Holas4, Sylwia Hyniewska11, Ewa Malinowska4, Bernice A Marcopulos12,13, Tricia L Merkley14, Jose A Muñoz-Moreno15, Clare Ramsden16, Christian Salas17, Sietske A M Sikkes18, Ana Rita Silva19, Imane Zouhar20. 1. Psychology Department, Faculty of Sciences, The University of New South Wales, Sydney, NSW, Australia. 2. St. Vincent's Applied Medical Research Centre, Peter Duncan Neuroscience Unit, Darlinghurst, Australia. 3. MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada. 4. Department of Clinical Neuropsychology and Psychotherapy, Faculty of Psychology, University of Warsaw, Warsaw, Poland. 5. Department of Psychology, University of Toronto; Centre for Neuropsychology and Emotional Wellness, Markham, ON, Canada. 6. Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK. 7. Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada. 8. Neuropsychology Unit, Consorci Sanitari de Terrassa, Barcelona, Spain. 9. Department of Adult Clinical Psychology, Institute of Psychology, The Maria Grzegorzewska University, Warsaw, Poland. 10. Department of Psychiatry & Mental Health, University of Cape Town, Cape Town, South Africa. 11. Division of Psychology and Language Sciences, University College London, London, UK. 12. Department of Graduate Psychology, James Madison University, Harrisonburg, USA. 13. Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, USA. 14. Department of Psychology and Neuroscience Center, Brigham Young University, Brigham, USA. 15. Infectious Diseases Department, Lluita contra la SIDA Foundation, Germans Trias i Pujol Hospital, Barcelona, Spain. 16. Tasmanian Health Service, Hobart, Australia. 17. Faculty of Psychology, Diego Portales University, Santiago, Chile. 18. Faculty of Behavioural and Movement Sciences, Department of Clinical, Neuro and Developmental Psychology, Amsterdam University Medical Centers & VU University, Amsterdam, the Netherlands. 19. Center for Research in Neuropsychology and Cognitive Behavioral Intervention - CINEICC, University of Coimbra, Coimbra, Portugal. 20. Department of Psychology, University of Toronto, Toronto, ON, Canada.
Abstract
OBJECTIVE: To propose a set of internationally harmonized procedures and methods for assessing neurocognitive functions, smell, taste, mental, and psychosocial health, and other factors in adults formally diagnosed with COVID-19 (confirmed as SARS-CoV-2 + WHO definition). METHODS: We formed an international and cross-disciplinary NeuroCOVID Neuropsychology Taskforce in April 2020. Seven criteria were used to guide the selection of the recommendations' methods and procedures: (i) Relevance to all COVID-19 illness stages and longitudinal study design; (ii) Standard, cross-culturally valid or widely available instruments; (iii) Coverage of both direct and indirect causes of COVID-19-associated neurological and psychiatric symptoms; (iv) Control of factors specifically pertinent to COVID-19 that may affect neuropsychological performance; (v) Flexibility of administration (telehealth, computerized, remote/online, face to face); (vi) Harmonization for facilitating international research; (vii) Ease of translation to clinical practice. RESULTS: The three proposed levels of harmonization include a screening strategy with telehealth option, a medium-size computerized assessment with an online/remote option, and a comprehensive evaluation with flexible administration. The context in which each harmonization level might be used is described. Issues of assessment timelines, guidance for home/remote assessment to support data fidelity and telehealth considerations, cross-cultural adequacy, norms, and impairment definitions are also described. CONCLUSIONS: The proposed recommendations provide rationale and methodological guidance for neuropsychological research studies and clinical assessment in adults with COVID-19. We expect that the use of the recommendations will facilitate data harmonization and global research. Research implementing the recommendations will be crucial to determine their acceptability, usability, and validity.
OBJECTIVE: To propose a set of internationally harmonized procedures and methods for assessing neurocognitive functions, smell, taste, mental, and psychosocial health, and other factors in adults formally diagnosed with COVID-19 (confirmed as SARS-CoV-2 + WHO definition). METHODS: We formed an international and cross-disciplinary NeuroCOVID Neuropsychology Taskforce in April 2020. Seven criteria were used to guide the selection of the recommendations' methods and procedures: (i) Relevance to all COVID-19 illness stages and longitudinal study design; (ii) Standard, cross-culturally valid or widely available instruments; (iii) Coverage of both direct and indirect causes of COVID-19-associated neurological and psychiatric symptoms; (iv) Control of factors specifically pertinent to COVID-19 that may affect neuropsychological performance; (v) Flexibility of administration (telehealth, computerized, remote/online, face to face); (vi) Harmonization for facilitating international research; (vii) Ease of translation to clinical practice. RESULTS: The three proposed levels of harmonization include a screening strategy with telehealth option, a medium-size computerized assessment with an online/remote option, and a comprehensive evaluation with flexible administration. The context in which each harmonization level might be used is described. Issues of assessment timelines, guidance for home/remote assessment to support data fidelity and telehealth considerations, cross-cultural adequacy, norms, and impairment definitions are also described. CONCLUSIONS: The proposed recommendations provide rationale and methodological guidance for neuropsychological research studies and clinical assessment in adults with COVID-19. We expect that the use of the recommendations will facilitate data harmonization and global research. Research implementing the recommendations will be crucial to determine their acceptability, usability, and validity.
Authors: Marco Aurélio G de Caneda; Daissy Liliana Mora Cuervo; Nathércia Estevam Marinho; Maria Cecília A de Vecino Journal: Dement Neuropsychol Date: 2018 Apr-Jun
Authors: Fernanda G De Felice; Fernanda Tovar-Moll; Jorge Moll; Douglas P Munoz; Sergio T Ferreira Journal: Trends Neurosci Date: 2020-04-21 Impact factor: 13.837
Authors: David R Darley; Gregory J Dore; Lucette Cysique; Kay A Wilhelm; David Andresen; Katrina Tonga; Emily Stone; Anthony Byrne; Marshall Plit; Jeffrey Masters; Helen Tang; Bruce Brew; Philip Cunningham; Anthony Kelleher; Gail V Matthews Journal: Med J Aust Date: 2021-03-03 Impact factor: 12.776
Authors: Karen Blackmon; Gregory S Day; Harry Ross Powers; Wendelyn Bosch; Divya Prabhakaran; Dixie Woolston; Otto Pedraza Journal: Res Sq Date: 2022-02-07